Vigil Neuroscience (VIGL) had the highest return between June 1, 2022 and October 30, 2022 by a small-cap US stock, returning 434.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Vigil Neuroscience (VIGL) | 6/1/2022 - 10/30/2022 | 434.78% |
Amylyx Pharmaceuticals (AMLX) | 6/1/2022 - 10/30/2022 | 304.45% |
Terns Pharmaceuticals (TERN) | 6/1/2022 - 10/30/2022 | 293.64% |
Enliven Therapeutics (ELVN) | 6/1/2022 - 10/30/2022 | 268.1% |
Day One Biopharmaceuticals (DAWN) | 6/1/2022 - 10/30/2022 | 244.35% |
Wave Life Sciences (WVE) | 6/1/2022 - 10/30/2022 | 227.54% |
Cogent Biosciences (COGT) | 6/1/2022 - 10/30/2022 | 204.77% |
89bio (ETNB) | 6/1/2022 - 10/30/2022 | 204.59% |
SS Innovations International Inc Common Stock (SSII) | 6/1/2022 - 10/30/2022 | 189.29% |
Avadel Pharmaceuticals (AVDL) | 6/1/2022 - 10/30/2022 | 179.56% |
Verve Therapeutics (VERV) | 6/1/2022 - 10/30/2022 | 166.71% |
Aehr Test Systems (AEHR) | 6/1/2022 - 10/30/2022 | 155.85% |
Biohaven Pharmaceutical (BHVN) | 6/1/2022 - 10/30/2022 | 155.5% |
Astria Therapeutics (ATXS) | 6/1/2022 - 10/30/2022 | 154.71% |
Dyne Therapeutics (DYN) | 6/1/2022 - 10/30/2022 | 139.75% |
Prothena (PRTA) | 6/1/2022 - 10/30/2022 | 127.15% |
Sigma Lithium Resources (SGML) | 6/1/2022 - 10/30/2022 | 123.11% |
UroGen Pharma (URGN) | 6/1/2022 - 10/30/2022 | 119.85% |
Bel Fuse B (BELFB) | 6/1/2022 - 10/30/2022 | 118.7% |
Yatsen (YSG) | 6/1/2022 - 10/30/2022 | 118.44% |
Ardelyx (ARDX) | 6/1/2022 - 10/30/2022 | 118.21% |
Cross Country Healthcare (CCRN) | 6/1/2022 - 10/30/2022 | 112.49% |
Kura Sushi USA (KRUS) | 6/1/2022 - 10/30/2022 | 109.88% |
Torm PLC Class A (TRMD) | 6/1/2022 - 10/30/2022 | 96.88% |
Clearfield (CLFD) | 6/1/2022 - 10/30/2022 | 96.04% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
